Researchers Neutralized Rattlesnake Venom With Proteins

A protein cocktail derived from snake serum successfully blocked lethal venom toxicity in mice.

Updated on Oct. 5, 2026 in Reptiles

A close-up of a clear glass laboratory beaker containing a liquid with a stirring rod, set in a sterile clinical laboratory environment.
University of Maryland researchers have identified a protein-based cocktail capable of neutralizing lethal rattlesnake venom, potentially offering a safer alternative to traditional antivenom. AI Illustration. Upload story photo >

Live Poll

Do you trust that biological discoveries from nature will lead to safer medical treatments?

Scientists have identified a family of proteins that effectively neutralize lethal rattlesnake venom. These proteins prevented death in mice injected with toxins from both Western and Eastern Diamondback rattlesnakes.

Why it matters

Current antivenom production is costly and can trigger adverse immune reactions in patients. Developing this protein-based method could offer a more efficient and safer alternative to traditional antibody-based treatments.

Researchers used a cocktail of two proteins to neutralize Western Diamondback venom and three proteins for the Eastern Diamondback. The protein family has evolved over 50 million years and inhibited metalloproteinases across four other pit viper species.

The players

University of Maryland

This public research university served as the primary institution for the lead researchers conducting the study.

Indian Institute of Science

This esteemed research university in India provided an external reviewer for the scientific findings.

The details

Researchers at the University of Maryland preincubated recombinant FETUA proteins with lethal venom doses before testing them on mice. By leveraging these proteins, which snakes naturally produce to protect themselves from their own toxins, scientists successfully blocked the typical damage caused by the more than 50 toxins present in most viper venom.

Timeline

  1. Researchers first isolated Fetuin-A from pit viper serum in the 1970s.

  2. Scientists identified the expansive scope of the FETUA protein family in 2022.

  3. The research findings were published on October 5, 2026.

The Big Picture

This discovery marks a departure from the historical method of antivenom production involving animal immunization by using synthetic proteins instead.

This advancement could eventually lead to safer and more accessible medical treatments for snakebite victims worldwide. If successfully scaled, patients might one day avoid the severe allergic reactions often associated with current animal-derived antivenoms.

The takeaway

By mimicking the natural defense mechanisms snakes have evolved over millions of years, scientists are opening new doors for human medicine. This approach highlights how biological research can bypass the need for traditional, labor-intensive medical manufacturing processes.

What happens next

Researchers are currently planning follow-up studies to determine if this specific protein-based neutralization strategy can be expanded to successfully combat additional types of venom toxins found in other species.

Further reading

For more on the latest research involving venomous species, explore our Reptiles section.

Source note: This article includes information reported by The Scientist.

Live Poll

Do you trust that biological discoveries from nature will lead to safer medical treatments?